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ABSTRACT:
Introduction: Neonatal seizure is the most common manifestation and an important determinant of outcome of 
neurological disorders in newborn period. This study aims to delineate the etiological profile and neurodevelopmental 
outcome of neonatal seizures and also to identify predictors for adverse outcome.
Methods: One hundred and seventeen neonates with clinically proven seizures admitted in Dhulikhel Hospital from 
February 2014 to February 2016 were recruited. All of them underwent necessary neurological diagnostic tests. The 
survivors were followed up for at least three times within the first 18 months of life. Prognostic value of factors for 
adverse outcomes were analyzed with Chi square test and binary logistic regression analysis.
Results: Among a total of 954 neonates admitted, 117 (12.26%) developed clinical seizures. The most common cause 
of neonatal seizure was hypoxic ischemic encephalopathy (n=69, 59%), followed by infection (n=20, 17.09%), and 
metabolic disturbances (n=16, 13.7%). The outcomes were mortality (n=16, 13.7%), post neonatal seizure (n=18, 
15.4%), developmental delay (n=31, 26.5%), vision impairment (n=19, 16.2%) and hearing impairment (n=26, 
22.2%). Low Apgar scores at one minute (p=0.03) and five minutes (p=0.001), early onset seizure (p<0.001), and 
more than one drug used for seizure control (p=0.001) were early prognostic factors for adverse outcome.
Conclusion: Birth asphyxia followed by infection and transient metabolic disturbance were common etiologies 
for neonatal seizures. Low Apgar scores at one and five minutes, early onset seizure, multiple episodes of seizures 
and requirement of multiple anti-epileptics to control seizures were found to be significant predictors for adverse 
neurodevelopmental outcome.
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INTRODUCTION:
 Neonatal seizures are usually an acute 
manifestation of disturbance of the developing brain 
and common in the early weeks of life. The incidence 
of seizure varies widely in different countries ranging 
from 1.8 to 5 per 1000 live births in the United States 
of America to 39.5 per 1000 live births in Kenya.[1,2] 
The predominant causes of neonatal seizures are 
hypoxic ischemic encephalopathy (HIE), followed 
by metabolic abnormalities, infection, intracranial 
hemorrhage and developmental abnormalities.[3,4]
 Several prognostic factors for adverse 
outcome of seizure are well known, namely brain 
immaturity, abnormal cranial ultrasonography 
(USG) findings, low Apgar score, early onset of 
seizure or prolonged duration of seizure.[5] Neonates 
with seizures are at an increased risk of mortality, 
and the survivors are at risk of neurological sequelae 
as developmental delay, epilepsy and cognitive 
impairment. We therefore need to initiate an early 
diagnostic work up to establish etiology, depending 
on the available facilities.[6] Establishing risk factors 
that might predict outcome of newborn with seizure 
would be helpful in planning long term follow up 
and health assistance to these children.
 Many studies have been published on risk 
factors, etiology and outcome of newborns with 
seizure from different countries. However, there is 
Submitted: May 04, 2018    Accepted: Nov 25, 2018
Published: Nov 30, 2018
a - Associate Professor, Department of Paediatrics
b - Professor, Department of Paediatrics
c - Lecturer, Department of Paediatrics
d - Dhulikhel Hospital, Kathmandu University School of Medical Sci-
ences, Dhulikhel
Corresponding Author:
Srijana Dongol Singh 
e-mail: docsrijana@yahoo.com
ORCID: https://orcid.org/0000-0001-6054-0197
How to cite this article:
Singh SD, Shrestha RBP, Shrestha A. Etiological Profile of Neonatal 
Seizures and Prognostic Factors for Adverse Outcome: A Single Center 
Prospective Study. Journal of Lumbini Medical College. 2018;6(2):8 
pages. DOI: 10.22502/jlmc.v6i2.212. Epub: 2018 Nov 27.
Singh SD. et al. Etiological Profile of Neonatal Seizures
jlmc.edu.npJ. Lumbini. Med. Coll. Vol 6, No 2, July-Dec 2018
a paucity of literature from our country that have 
examined the causes, risk factors and outcomes of 
neonatal seizures. The aims of the current study are 
to describe the etiologic profile, neurodevelopmental 
outcome and reliable prognostic indicators of 
outcome of infants surviving neonatal seizures.
METHODS:
 This was an observational prospective study 
in a cohort of newborns with clinically proven 
seizures. The survivors  were followed up in our 
high risk outpatient clinic for at least 18 months. 
Newborns included in the study were neonates 
with seizures admitted in the Neonatal Intensive 
Care Units (NICU) of Dhulikhel Hospital from 
February 2014 to February 2016. Ethical approval 
for the study was obtained from Institutional Review 
Committee of Kathmandu University School of 
Medical Sciences.
 Seizures were defined as reported or observed 
repeated involuntary muscle contractions, abnormal 
tonic extensions or jerky movements of any part 
of the limb, face or mouth that was not stimulus 
sensitive or repetitive abnormal chewing, ocular or 
pedalling movements. Seizures were then classified 
after clinical observation and correct description of 
seizure type.
 The time of occurrence of the seizure was 
categorized according to the age at onset as seizure 
occurring within the first 24 hours, between 24 to 
72 hours and  after 72 hours.  It was considered 
early if seizures started within 72 hours of life 
and late if  started after 72 hours. The frequency 
of seizure was also recorded as single or multiple 
episodes. Gestational age was determined according 
to modified Ballard  scale.[7]  The different modes 
of delivery were also recorded. The Apgar scores 
at one and five minutes after birth were noted. 
Maternal risk factors  as family history of neonatal 
seizure, maternal illness, maternal medication, 
complications during pregnancy (prolonged second 
stage of labour and placental or cord complications) 
were also recorded.
 The primary etiology of the seizure was 
ascertained through clinical history, neuroimaging 
studies [computer tomography (CT), cranial USG 
and/or magnetic resonance imaging (MRI)] when 
indicated. Laboratory tests as cerebrospinal fluid 
(CSF) analysis , serum glucose, serum electrolyte 
level and arterial blood gas analysis were done in 
required cases. Some infants underwent Toxoplasma 
gondii, Rubella, Cytomegalovirus and Herpes 
simplex virus (TORCH) screen for congenital 
infection. Diagnosis of neonatal sepsis was based on 
clinical manifestations, sepsis work-up and positive 
blood culture. 
 Cranial USG was done in almost all infants. 
Some had at least one additional modality of 
imaging, such as cranial CT or MRI. The intracranial 
hemorrhage group included infants with extra-axial 
(epidural, subdural and subarachnoid) hemorrhage 
or intra-parenchymal hemorrhage. Developmental 
cerebral defect, cerebral infarction and hydrocephalus 
if any present, were also documented.
 We divided etiology into seven groups: 
(1) Hypoxic ischemic encephalopathy (HIE), (2) 
transient metabolic disturbance, (3) infection, (4) 
intracranial hemorrhage, (5) developmental cerebral 
defect, (6) benign familial neonatal seizure and (7) 
unknown etiology, if diagnostic evaluation revealed 
no etiology.
 The drug of first choice was intravenous 
phenobarbitone at a loading dose of 20-40 mg/
kg and a maintenance dose of 3-8 mg/kg/day. In 
case of persistence or recurrence of seizures, we 
administered intravenous phenytoin at a loading dose 
of 20mg/kg and a maintenance dose of 4-8 mg/kg/
day. If seizure still persisted, continuous intravenous 
infusion of midazolam at 1-10 microgram/kg/
day was given. Few neonates had to be ventilated 
because of refractory seizure despite continuous 
infusion of midazolam. The number of antiepileptic 
drugs (AED) needed for control of seizures was also 
recorded. 
 All the survivors were followed up for at 
least three times in the first 18 months of life i.e. 
around two months, between six and nine completed 
months and between 11 and 18 completed months 
in the High-Risk Clinic of Pediatric outpatient 
department. They were evaluated thoroughly 
by physical examination and developmental 
assessment. At the same time infants were seen by 
physiotherapist, ophthalmologist and audiologist 
whenever necessary. In this study we evaluated 
the outcome by developmental progress, growth of 
head, visual impairment, hearing impairment and 
the presence of seizure after NICU discharge. 
Statistical analysis:
 Data were entered to and analyzed using 
Statistical Package for Social Sciences (SPSSTM)
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version 16. Quantitative data were presented in 
mean ± SD and qualitative data in frequency and 
percentages. The association of neonatal seizures 
in different clinical conditions were assessed by 
Pearson Chi square test and Fisher's exact test. The 
risk factors for different adverse outcomes were 
assessed applying binary logistic regression analysis. 
P value less than 0.05 was considered  significant.
RESULTS:
 Among total neonates admitted to NICU 
during the study period, 117 (12.26%) neonates had 
developed clinical seizure. Seventy five (64.1%) 
neonates were male and 42 (35.9%) were female. 
The male to female ratio was 1.7:1. One hundred 
(85.47%) neonates were term, whereas 17(14.52%) 
were preterm. The mode of delivery in 73 (62.39%) 
neonates was  vaginal delivery , 37 (31.62%) was 
cesarean section (CS) and 7 (5.98%) was instrumental 
delivery. Twenty seven (23.07%) neonates were 
born to mother who had history of prolonged 
second stage of labor and nine (7.69%) to those with 
history of placental or cord complications. Fifty 
two (44.44%) neonates had first episode of seizure 
before 24 hours, 31 (26.49%)  between 24 and 72 
hours and 34 (29.05%)  after 72 hours (late onset). 
In this study, 62 (53%) neonates had single episode 
of seizure while 55 (47%)  had multiple episodes of 
seizure. Abnormal neuroimaging were seen only in 
11 (9.4%) neonates. Among all neonates 78 (66.66%) 
needed only one antiepileptic medication to control 
seizure while 39 (33.33%) needed multiple drugs 
(Table 1).
 The most common etiology for neonatal 
seizure was birth asphyxia (n=69, 59%), followed 
by infection (n=20, 17%) and transient metabolic 
disturbance (n=16, 13.7%). There was one neonate 
with no identified etiology (Fig.1).
 Sixteen (13.67%) patients died during or after 
neonatal period. Among 101 neonates discharged 
after survival, 18(15.4%) patients had repeated 
seizures during the follow up period, 31(26.5%) 
had developmental delay, 19(16.2%) had vision 
impairment and 26(22.2%) had hearing impairment. 
Low Apgar score at one minute (p=0.003), Low 
Apgar score at five minutes (p=0.001), early onset 
of seizures (p<0.001), multiple episodes of seizure 
(p<0.001), multiple anti-epileptics used to control 
seizure (p<0.001) were notable risk factors for 
adverse outcome (Table 1).
 Analysis of various risk factors for 
developmental delay by binary logistic regression 
showed that neonates with single episode of seizure 
were less likely to develop developmental delay 
Table 1. Outcome of neonatal seizures in different clinical conditions (N=117)
Variables Normal outcome Adverse outcome Statistics 
Sex Male 44 35 X2 (df=1, N=117)= 0.245, p=0.621Female 23 15
Gestational age Term 59 41 X2  (df=1, N=117)=0.847, p=0.358Preterm 8 9
Mode of delivery 
Vaginal 43 30
X2  (df=2, N=117)=2.508, p=0.285Cesarean section 22 15
Instrumental 2 5
Onset of seizures
Within 24 hours 20 32 
X2  (df=2, N=117)= 15.207, p= 
<0.00124 to 72 hours 25 6 
After 72 hours 22 12 
Apgar at 1 min
0-3 17 27 
X2  (df=2, N=117)=11.665, p=0.0034-6 31 18 
7-10 19 5 
Apgar at 5 mins
0-3 1 7 
F  (df=2, N=117)=14.096, p=0.001 4-6 27 29 
7-10 39 14 
Type of seizure 
Subtle 16 16 
X2  (df=3, N=117)=20.696, 
p=<0.001 
Tonic 35 12 
Clonic 13 6 
Mixed 3 16 
Episodes of 
seizure
Single 56 6 X2  (df=1, N=117)=58.896, 
p=<0.001Multiple 11 44
AED Single 63 16 X
2  (df=1, N=117)=50.237, 
p=<0.001Multiple 4 34
Neuroimaging
Normal 18 10 X2 (df=1, N=44)=2.946, p=0.086Abnormal 6 10
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Birth asphyxia n=69 
(59%)
- HIE II n=48 (69.56%)
- HIE III n=21 (30.43%)Transient metabolic 
disturbance
n=16 (14%)
-Hypoglycemia n=6 
(37.5%) 
- Hyponatremia  n=3 
(18.75%)
- Hypernatremia n=6 
(37.5%)
- Hypocalcemia n=1 
(6.25%)
Infection n=20 (17%)
- Meningitis n=10(50%)
- Septicemia n=9(45%)
- Congenital n=1(5%)
Benign Neonatal 
seizure n=3(3%)
Developmental 
cerebral dysgenesis 
n=4(3%) ICH n=4 (3%) Unknown…
Fig. 1. Etiological Distribution of Neonatal Seizure (N=117)
Variables Frequency (%) AOR (95% CI) p value
Sex 
Male
Female
67(66.33)
34(33.66)
45938(0.087-2.4E+10)
0.110
Gestational age
Term
Preterm
88(87.12)
13(12.87)
0.00(0.00-2.20)
0.073
Mode of delivery
Vaginal delivery
C.S
Instrumental delivery
64(63.36)
32(31.68)
5(4.95)
101.14(0.00-9.47E+7)
19.01(0.00-1.71E+7)
0.424
0.510
0.674
Apgar Score at 1 min
0-3
4-6
7-10
32(31.68)
47(56.53)
22(21.78)
0.20(0.00-461.91)
0.13(0.00-70.29)
0.809
0.685
0.528
Apgar score at 5 mins
0-3
4-6
7-10
4(3.96)
47(46.53)
50(49.50)
4.8E+11(0.00-1.2E+29)
1650291(0.40-6.6)
0.182
0.188
0.065
Maternal risk factors Prolonged second stage of labour
Placental or cord complications
19(18.81)
 8(7.93)
0.012(0.00-28.98)
0.11(0.003-4.79)
0.267
0.252
Onset of seizure
<24hours
24-72 hours
>72 hours
39(38.61)
30(29.70)
32(31.68)
0.012(0.00-2.36)
0.00(0.00-1.57) 0.100
0.062
Episode of seizure Single
Multiple
62(61.38)
39(38.68)
0.00(0.00-0.67)
0.044
Abnormal neurological 
finding
Yes
No
11(29.72)
26(70.27)
326(0.33-3270842)
1155.79(0.25-5.37E+7)
0.218
0.198
Antiepileptic 
medication
Single
Multiple
77(76.23)
24(23.76)
0.001(0.00-7.94)
0.137
Table 2. Risk factors for developmental delay (N=117)
as compared to multiple episodes of seizure [AOR 
(95%CI)=0.00(0.00-0.67), p=0.044]. The odds of 
having developmental delay was 33% to 100% lower 
in those neonates with single episode of seizure in 
comparison to multiple episodes. The incidence of 
developmental delay was high among the neonates 
whose Apgar score was low at one minute and 
among those that developed seizure within 24 
hours; however,  these findings were statistically not 
significant (Table 2).
 Post neonatal seizures were more common 
in male term babies delivered vaginally; however, it 
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Variables frequency (%)
AOR (95% CI)
P value
Sex Male
Female
67(66.33)
34(33.66)
0.374 (0.022-6.337)
0.495
Gestational Age Term
Preterm
88(87.12)
13(12.87)
0.574 (0.028-11.757)
0.718
Mode of delivery
Normal vaginal delivery
C.S
Instrumental delivery
64(63.36)
32(31.68)
5(4.95)
0.229 (0.001-38.077)
0.816 (0.004-164.363)
0.572
0.940
0.551
Apgar Score at 1 min
0-3
4-6
7-10
32(31.68)
47(56.53)
22(21.78)
104 (1.24-870)
8.28 (0.34-200)
0.043
0.193
0.123
Apgar Score at 5 mins
0-3
4-6
7-10
4(3.96)
47(46.53)
50(49.50)
205162 (0.00-1.17)
0.28 (0.007-12.09)
0.997
0.514
0.808
Maternal risk factors Prolonged second stage of labour
Placental or cord complications
19(18.81) 
8(7.93)
1.8 (0.10-31.40)
2.48E+9 (0.00)
0.669
0.998
Onset of seizure
<24hours
24-72 hours
>72 hours
39(38.61)
30(29.70)
32(31.68)
0.11(0.03-3.74)
1.09 (0.08-14.65)
0.220
0.948
Episode of seizure Single
Multiple
62(61.38)
39(38.68)
0.00 (0.00-)
0.994
Abnormal 
neurological finding Yes
No
11(29.72)
26(70.27)
0.177(0.08-3.77)
0.437 (0.16-11.65)
0.268
0.621
Antiepileptic 
medication
Single
Multiple
77(76.23)
24(23.76)
0.64(0.07-5.67)
0.689
Table 3. Risk factors for post neonatal seizure ( N=117)
was not statistically significant. Low Apgar score (0-
3) at one minute was the single most risk factor for 
post neonatal seizure(p=0.043). The neonates with 
low Apgar score (0-3) had 104 times more odds of 
developing post neonatal seizures in comparison to 
those with normal Apgar score (7-10) (Table 3).
Multivariable binary logistic regression analysis 
showed that multiple episodes of seizure (p<0.001) 
and Apgar score (4-6) at five minutes (p=0.046) 
were statistically significant risk factors for 
hearing impairment. Similarly, mode of delivery 
especially vaginal delivery (p=0.01) and cesarean 
section (p=0.03) were less likely to result in vision 
impairment in comparison to instrumental delivery. 
Multiple episodes of seizure (p=0.005) and abnormal 
neurological findings (p=0.045) were also found 
to be statistically significant risk factors for vision 
impairment (Table 4).    
   
DISCUSSION:
 The overall incidence of neonatal seizures in 
our study was 12.26%. This incidence is similar to 
that in established intensive care units which is as 
high as 25% in NICU.[8] The seizures were more 
common in males (63.36%) which is similar to the 
study done by Alyasiri AA[9](63.9%), Sabzehaei 
et al.[3] (57%) and Jasim M et al.[4](54.5%).The 
majority of neonates who developed seizures were 
full term (85.47%) which is comparable to the finding 
of Alyasiri AA (91%).[9] A majority of neonates in 
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Frequency  
(%)
Hearing impairment Vision impairment
AOR (95% CI) p value AOR (95% CI)  p value
Sex Male
Female
67 (66.33)
34 (33.66)
10.77 (1.41-82.71)
0.022
6.27 (0.79-49.70)
0.08
Gestational 
Age
Term
Preterm
88 (87.12)
13 (12.87)
0.765 (0.07-7.86)
0.822
0.14 (0.01-1.70)
0.12
Mode of 
delivery
vaginal delivery
C.S
Instrumental 
delivery
64 (63.36)
32(31.68)
5 (4.95)
0.58 (0.02-12.2)
0.24 (0.01-5.34)
0.73
0.37
0.004 (0.00-0.38)
0.009 (0.00-0.63)
0.01
0.03
Apgar Score at 
1 min
0-3
4-6
7-10
32 (31.68)
47 (56.53)
22 (21.78)
2.70 (0.09-81.61)
3.63 (0.29-45.04)
0.56
0.31
17.40 (0.33-915)
2.54 (0.18-35.03)
0.15
0.48
Apgar Score at 
5 mins
0-3
4-6
7-10
4 (3.96)
47 (46.53)
50 (49.50)
25.43 (0.45-1409)
10.66 (1.03-109)
0.114
0.046
42.02 (0.69-255)
7.69 (0.45-131.55)
0.07
0.15
Maternal risk 
factor
Prolonged second 
stage labor
Placental or cord 
complication
19 (18.81)
8 (7.93)
0.77 (0.12-4.90)
2.69 (0.15-47.75)
0.78
0.49
4.13 (0.30-56.38)
0.11 (0.005-2.841)
0.28
0.18
Onset of 
seizure
<24hours
24-72 hours
>72 hours
39 (38.61)
30 (29.70)
32 (31.68)
1.20 (0.12-11.47)
1.03 (0.14-7.59.0)
0.86
0.97
0.07 (0.003-1.584)
0.96 (0.108.95)
0.09
0.97
Episode of 
seizure
Single
Multiple
62(61.38)
39(38.68)
0.014 (0.002-0.124)
<0.001
0.002 (0.00-0.15)
0.005
Abnormal 
neurological 
finding
Yes
No
11 (29.72)
26 (70.27)
0.46 (0.05-3.81)
0.47
0.121 (0.16-0.016)
0.045
Antiepileptic 
medication
Single
Multiple
77 (76.23)
24(23.76)
1.32 (0.19-8.89)
0.77
1.03 (0.13-7.78)
0.97
our study population were born via vaginal delivery 
(62.39%). Similar results were also seen in the 
study done by Talebian A et al. in Iran with seizure 
incidence in vaginal delivery of 65.61% compared to 
34.4% in CS.[10] We found that 52(44.44%)  of the 
neonates had seizure of early onset. This is similar to 
the findings of Faiz N et al.[8] in which early onset 
seizure was found in 59% and in another study by 
Alyasiri AA [9] where early onset seizure was found 
in 50.8%.
 In our study, perinatal asphyxia was the 
leading cause of neonatal seizures (59%) although the 
incidence varies in different studies as a result of the 
inconsistent diagnostic criteria used. This finding is 
comparable to studies by Sahana et al.[11] and Loman 
AM et al.[12]in which neonatal seizures following 
HIE had occurred in 57.8% and 53.9% respectively. 
Infections were the second most common cause of 
seizure in our study which comprised almost 17.09% 
which was similar to study by Alyasiri AA (16.4%).
[9] Another common cause of neonatal seizure in the 
current study was transient metabolic disturbance 
Table 4. Risk factors for vision and hearing impairment ( N=117)
(n=16, 13.6%), which was comparable to studies by 
Sahana et al.[11] In our study, hypoglycemia was the 
most common transient metabolic disturbance (n=6) 
comprising 5.12% of total etiology and 37.5% of 
transient metabolic disturbance. This was supported 
by the other studies as well.[9,10]
 In this study, beside three major etiologies, 
the other etiologies for seizure were intracranial 
hemorrhage, developmental cerebral dysgenesis and 
benign neonatal seizure. Many other studies reported 
similar findings.[9,13]
 We found statistically significant relationship 
between low Apgar scores (0-3) at one and five 
minutes, early onset seizure (<24 hours), multiple 
episodes of seizure, number of antiepileptic drugs 
needed to control seizure and neonatal outcome. 
Similar  to our study, other studies by Lai YH et 
al.[14] and Pisaniet F et al.[15] found that  low 
Apgar scores at one and five minutes and early onset 
of seizure were prognostic factors for poor outcome. 
We did not find a significant relationship between 
abnormal neuroimaging finding and seizure outcome 
(p=0.086). This finding differs from other reports in 
which abnormal neuroimaging has been associated 
with worse outcome.[14,15] This could possibly 
be explained by the fact that only minor anomalies 
were found in neuroimaging in most of the neonates 
and only few neonates had major malformations or 
pathological conditions.  
 The only variable significantly related to 
developmental delay was multiple episodes of seizure 
(p=0.044). The finding differs from other reports in 
which abnormal neuroimaging and prematurity were 
significantly related to developmental delay while 
multiple episodes was not.[13] Developmental delay 
was more dependent on etiology and duration of 
seizure rather than the episode of seizure. Similar to 
our study, another study by Echandia et al. showed 
low five minutes Apgar score was not an effect 
modifier neither a confounder of the association 
between neonatal seizure and developmental delay.
[16]
 The only variable significantly related to post 
neonatal seizure was low Apgar score at one minute. 
Eighteen (15.4%) newborns recruited to our study 
developed seizure later in life which is comparable 
to the study done by Francesco P et al.[17]where 
17.6% of the newborns developed epilepsy later in 
life. The study  also showed no significant relation 
of mode of delivery, gestational age and onset of 
seizure with post neonatal seizure similar to our 
study.
The present study found significant occurrence of 
hearing loss among infants with the history of low 
Apgar  score at five minutes. This finding was similar 
to another study done in Gauhati Medical College 
Hospital, India.[18] Similar to another study by 
Pisani F et al.[15] this study also showed association 
of multiple episodes of seizure with poor neurologic 
outcome including vision and hearing loss. 
Limitation:
Since neonatal seizures are often subclinical, EEG 
recording of electrographic seizures is crucial for 
estimation of true seizure burden which could not be 
done in our setup. The number of neonates was less 
as it was a single center study and follow up was not 
done for longer periods.
CONCLUSION: 
 The most common cause of neonatal 
seizures was  HIE followed by infection and 
transient metabolic disturbances. Neonatal seizures 
predominated in term, male newborns and vaginal 
delivery with low Apgar score. Furthermore, the 
follow up showed an increased risk of developmental 
delay and hearing impairment in most infants. 
We found five variables in neonates with neonatal 
seizures for providing early prognostic information 
on adverse outcome: low Apgar scores at one and 
five minutes, early onset seizure, multiple episodes 
of seizures and multiple anti-epileptics needed to 
control seizures.
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